Displaying 1 - 2 of 2
| Active Ingredient | FAMOTIDINE |
| Therapeutic Class | HISTAMINE RECEPTOR ANTAGONIST |
| Indications | Gastric, duodenal ulcers, GERD and Zollinger Ellison Syndrome. |
| Caution | Headaches, dizziness, constipation. C.f. prescribing in renal disease p. 29. |
| Dose Range | Adult: Gastric/Duodenal Ulcer:40mg at night for 4-8 weeks; maintenance 20mg at night. GERD: 20 mg twice daily for 6 to 12 weeks, or up to 40 mg twice daily if there is oesophageal erosion or ulceration.. Inj:20mg over 2 mins.every 12 hours. Pediatric |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | RANITIDINE |
| Therapeutic Class | HISTAMINE RECEPTOR ANTAGONIST |
| Indications |
Treatment of peptic ulcer disease, GERD and Zollinger Ellison Syndrome. |
| Caution |
See Famotidine. c.f. prescribing in liver and renal disease p. 17; 36. |
| Dose Range |
Adult and children 12 years and over: 150mg twice daily with breakfast or at night; or 300mg as a single dose at night. Maintenance: 150mg at night. i.m/i.v 50mg given slowly over 2 minutes repeated every 6-8 hours. Pediatric 3-12 yrs: |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |